tiprankstipranks
Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market

Caribou Biosciences (CRBU) Income Statement

Compare
694 Followers

Caribou Biosciences Income Statement

Last quarter (Q3 2024), Caribou Biosciences's total revenue was $2.02M, a decrease of -91.45% from the same quarter last year. In Q3, Caribou Biosciences's net income was $-34.68M. See Caribou Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 34.48M$ 13.85M$ 9.60M$ 12.36M$ 5.79M
Gross Profit
$ -77.60M$ 10.21M$ 8.61M$ -22.06M$ -17.85M
Operating Expenses
$ 150.54M$ 120.25M$ 76.58M$ 48.48M$ 40.09M
Depreciation and Amortization
$ 3.52M$ 3.64M$ 984.00K$ 900.00K$ 751.00K
EBITDA
$ -112.53M$ -104.78M$ -66.00M$ -35.21M$ -30.21M
Operating Income
$ -116.06M$ -106.40M$ -66.98M$ -36.12M$ -34.30M
Other Income/Expenses
$ 14.18M$ 7.05M$ 377.00K$ -3.00K$ 3.34M
Pretax Income
$ -101.88M$ -99.35M$ -66.60M$ -36.13M$ -30.97M
Net Income
$ -102.07M$ -99.42M$ -66.92M$ -34.31M$ -23.43M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.38$ -1.64$ -1.11$ -0.57$ -0.39
Diluted EPS
$ -1.38$ -1.64$ -1.11$ -0.57$ -0.39
Weighted Average Shares Outstanding
73.81M 60.80M 60.26M 59.97M 59.97M
Weighted Average Shares Outstanding (Diluted)
73.81M 60.80M 60.26M 59.97M 59.97M
Currency in USD

Caribou Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis